Home > Publications Database > ALL-R: An Anchoring Score to Predict Relapse in Acute Lymphoblastic Leukemia (ALL) Using a Zebrafish Patient-Derived Xenograft Model > print

001     273929
005     20250120102327.0
024 7 _ |a 10.1182/blood-2024-209569
|2 doi
024 7 _ |a 0006-4971
|2 ISSN
024 7 _ |a 1528-0020
|2 ISSN
037 _ _ |a DZNE-2024-01403
082 _ _ |a 610
100 1 _ |a Arner, Anja
|b 0
111 2 _ |a 66th American Society of Hematology Annual Meeting
|g ASH
|c San Diego
|d 2024-12-07 - 2024-12-10
|w USA
245 _ _ |a ALL-R: An Anchoring Score to Predict Relapse in Acute Lymphoblastic Leukemia (ALL) Using a Zebrafish Patient-Derived Xenograft Model
260 _ _ |a Washington, DC
|c 2024
|b American Society of Hematology
300 _ _ |a 275
336 7 _ |a CONFERENCE_PAPER
|2 ORCID
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|m journal
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a Output Types/Conference Paper
|2 DataCite
336 7 _ |a Contribution to a conference proceedings
|b contrib
|m contrib
|0 PUB:(DE-HGF)8
|s 1736775175_13802
|2 PUB:(DE-HGF)
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Blaser, Bradley Wayne
|b 1
700 1 _ |a Ettinger, Andreas
|b 2
700 1 _ |a Schmid, Bettina
|0 P:(DE-2719)2241638
|b 3
|u dzne
700 1 _ |a Jeremias, Irmela
|b 4
700 1 _ |a Binder-Blaser, Vera
|b 5
773 _ _ |a 10.1182/blood-2024-209569
|g Vol. 144, no. Supplement 1, p. 275 - 275
|0 PERI:(DE-600)1468538-3
|n Supplement 1
|p 275
|t Blood
|v 144
|y 2024
|x 0006-4971
856 4 _ |u https://pub.dzne.de/record/273929/files/DZNE-2024-01403_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/273929/files/DZNE-2024-01403_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:273929
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2241638
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BLOOD : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b BLOOD : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-2719)1140002
|k AG Schmid München
|l Genetic Models of Neurodegeneration
|x 0
980 _ _ |a contrib
980 _ _ |a VDB
980 _ _ |a journal
980 _ _ |a I:(DE-2719)1140002
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21